| Metric | Value ($ M) | Q1 FY25 |
|---|---|---|
| Revenue | 3.6K | 25.6% |
| Total Income | 3.6K | 25.6% |
| Expenditure | 3.5K | 23.5% |
| PBT | 82.83 | 822.4% |
| Net Profit | 148.77 | 403.6% |
| OPM | 3.36% | 1.60pp |
| NPM | 4.12% | 3.09pp |
| EPS | 0.73 | 386.7% |
BrightSpring Reports Q1 2026 Revenue Up 26% and Increases FY26 Guidance
03 May 2026 · 3 May, 5:14 pm
Summary
BrightSpring Health Services, Inc. announced its financial results for the first quarter ended March 31, 2026, reporting a 25.6% increase in net revenue to $3,614 million. Gross profit rose by 42.5% to $482 million, and net income reached $74 million, significantly higher than the $9 million reported in the same quarter of the previous year. Adjusted EBITDA also saw a substantial increase of 44.8%, reaching $190 million. The company has increased its full year 2026 revenue and Adjusted EBITDA guidance, reflecting confidence in its continued growth and performance.
Key Highlights
- 1
BrightSpring Health Services reported net revenue of $3,614 million for the first quarter of 2026, an increase of 25.6% compared to $2,878 million in the first quarter of 2025.
- 2
Gross profit for Q1 2026 was $482 million, up 42.5% compared to $338 million in the first quarter of 2025.
- 3
Net income for the first quarter of 2026 reached $74 million, compared to $9 million in the first quarter of 2025.
- 4
Adjusted EBITDA for Q1 2026 increased by 44.8% to $190 million, compared to $131 million in the first quarter of 2025.
- 5
The company's leverage was 2.27x as of March 31, 2026, compared to pro forma leverage of 2.60x on December 31, 2025.
- 6
BrightSpring is increasing its full year 2026 revenue guidance to $14,725 million to $15,225 million, representing 14.1% to 17.9% growth.
- 7
The company is also increasing its full year 2026 Adjusted EBITDA guidance to $795 million to $825 million, representing 28.7% to 33.6% growth.
Management Comments
Jon Rousseau
We are pleased with the Company’s first quarter results, which reflect the team’s commitment to patients as well as the operating and growth priorities discussed at the Investor Day in March. Our focus continues to be anchored in operational and commercial best practices across the organization while leveraging scale to provide quality and effective services to complex patient populations. As we look ahead to the remainder of 2026, we are focused on growing each of our businesses while executing against our goals and reaching more patients who can benefit from these highly impactful and valuable services.
Informational and educational content only. Not investment advice.